BioCryst Pharma (NASDAQ:BCRX) is set to give its latest quarterly earnings report on Monday, 2024-02-26. Here’s what investors need to know before the announcement.
Analysts estimate that BioCryst Pharma will report an earnings per share (EPS) of $-0.24.
BioCryst Pharma bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the …
Leave a Reply